Cellular activation induced by BCG is a PTK-dependent event
P Méndez-Samperio1, M Hernandez-Garay, A N Vazquez
1Departamento de Immunología, Escuela Nacional de Ciencias Biológicas, Carpio y Plan de Ayala, México.
Insights
Protein tyrosine kinases (PTKs) are crucial for BCG-induced immune cell activation. Inhibiting PTKs with genistein or tyrphostin significantly reduced cell proliferation and TNF-alpha release, indicating PTK
Area of Science:
- Immunology
- Cellular Signaling
Background:
- Mycobacterial antigens, including BCG, activate immune cells, leading to proliferation and cytokine release.
- The precise signaling pathways governing BCG-induced immune cell activation remain incompletely understood.
Purpose of the Study:
- To investigate the role of protein tyrosine kinases (PTKs) in BCG-induced human peripheral blood mononuclear cell activation.
- To determine if PTK inhibition affects BCG-stimulated cellular proliferation and inflammatory cytokine production.
Main Methods:
- Utilized PTK inhibitors genistein and tyrphostin to block PTK activity.
- Assessed BCG-induced cell growth via thymidine uptake assays.
- Quantified TNF-alpha secretion levels.
- Evaluated cell viability using trypan blue staining.
- Tested for LPS contamination.
- Used monoclonal antibodies against HLA-DR and DQ.
Main Results:
- Genistein significantly inhibited BCG-induced cell growth and TNF-alpha secretion in a dose-dependent manner (92% inhibition at 50 microM).
- Tyrphostin also strongly inhibited BCG-induced TNF-alpha secretion (81% inhibition at 30 microM).
- Inhibitory effects were not due to altered cell viability or LPS contamination.
- Monoclonal antibodies against HLA-DR and DQ also inhibited TNF-alpha secretion.
Conclusions:
- Protein tyrosine kinases (PTKs) play a significant role in BCG-induced cellular activation.
- PTK signaling pathways are essential for mediating BCG-induced immune responses, including proliferation and TNF-alpha release.
Abstract:
Mycobacterial antigens including BCG stimulate human peripheral blood mononuclear cells resulting in cellular proliferation and the release of inflammatory cytokines such as TNF-alpha. However, the signal transduction mechanisms responsible for the BCG-induced cell activation are not completely understood. In this study, we investigated the role of PTK as a signal transduction pathway in BCG-induced cell activation, with the use of two PTK inhibitors (genistein and tyrphostin). Our results indicated that genistein significantly inhibited BCG-induced cell growth determined by thymidine uptake in a dose-dependent manner. BCG-induced TNF-alpha secretion was completely suppressed by genistein in a dose-dependent manner, producing 92% inhibition at a concentration of 50 microM. In addition, strong inhibition (81%) of BCG-induced TNF-alpha secretion was observed with tyrphostin (30 microM), another specific protein tyrosine kinase with a different mechanism of action. These inhibitory effects were not attributed to an alteration in cell viability as judged by trypan blue staining, and were not due to LPS contamination. On the other hand, monoclonal antibodies directed against HLA-DR and DQ inhibited the BCG-induced secretion of TNF-alpha. Taken together, these findings suggest that PTK may play an essential role in BCG-induced cellular activation.
Related Concept Videos
Mitogens and the Cell Cycle
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
TGF - β Signaling Pathway
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...


